why choose us

First received: May 18, 2023

Clinical Trial: A Study of XmAb23104 in People With Sarcoma

Study Status: ACTIVE_NOT_RECRUITING

Recruit Status: ACTIVE_NOT_RECRUITING

Condition: Sarcoma

Study Type: INTERVENTIONAL


Official Title: Phase II Study of XmAb23104 (Targeting PD-1 and ICOS), in Patients With Advanced Sarcoma

Brief Summary: The purpose of this study is to find out whether the study drug, XmAb23104, is an effective treatment for advanced sarcoma.The researchers will also look at whether XmAb23104 is safe and causes few or mild side effects in participants.

Read more